Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3β

Abstract EN

Isoorientin has anti-inflammatory effects; however, the mechanism remains unclear.

We previously found isoorientin is an inhibitor of glycogen synthase kinase 3β (GSK3β) in vitro.

Overactivation of GSK3β is associated with inflammatory responses.

GSK3β is inactivated by phosphorylation at Ser9 (i.e., p-GSK3β).

Lithium chloride (LiCl) inhibits GSK3β and also increases p-GSK3β (Ser9).

The present study investigated the anti-inflammatory effect and mechanism of isoorientin via GSK3β regulation in lipopolysaccharide- (LPS-) induced RAW264.7 murine macrophage-like cells and endotoxemia mice.

LiCl was used as a control.

While AKT phosphorylates GSK3β, MK-2206, a selective AKT inhibitor, was used to activate GSK3β via AKT inhibition (i.e., not phosphorylate GSK3β at Ser9).

The proinflammatory cytokines TNF-α, IL-6, and IL-1β were detected by ELISA or quantitative real-time PCR, while COX-2 by Western blotting.

The p-GSK3β and GSK3β downstream signal molecules, including NF-κB, ERK, Nrf2, and HO-1, as well as the tight junction proteins ZO-1 and occludin were measured by Western blotting.

The results showed that isoorientin decreased the production of TNF-α, IL-6, and IL-1β and increased the expression of p-GSK3β in vitro and in vivo, similar to LiCl.

Coadministration of isoorientin and LiCl showed antagonistic effects.

Isoorientin decreased the expression of COX-2, inhibited the activation of ERK and NF-κB, and increased the activation of Nrf2/HO-1 in LPS-induced RAW264.7 cells.

Isoorientin increased the expressions of occludin and ZO-1 in the brain of endotoxemia mice.

In summary, isoorientin can inhibit GSK3β by increasing p-GSK3β and regulate the downstream signal molecules to inhibit inflammation and protect the integrity of the blood-brain barrier and the homeostasis in the brain.